MOLECULAR CLONING AND SEQUENCE ANALYSIS OF TES-120 GENE OF Toxocara canis EXCRETORY-SECRETORY ANTIGEN
175 / 40
Keywords:
Cloning, Excretory-Secretory antigen, Sequencing, TES-120, Toxocara canisAbstract
The gene encoding the excretory-secretory antigen of TES-120 from larvae of Toxocara canis was cloned and the sequence was analyzed for utilization as a diagnostic molecule. The total RNA was isolated from T. canis infective larvae and reverse transcription was done with oligo dT primers to obtain complementary DNA (cDNA). Amplification by PCR was performed with cDNA as a template and specific primers of the gene of TES-120, yielding an amplicon size of 530 bp. The amplicon was cloned into pRSETa expression vector. The recombinant clones were transformed into BL21 (DE3) pLysS E. coli expression host and the clone was confirmed by colony PCR, restriction enzyme analysis and sequencing. The nucleotide sequencing of TES-120 gene of TN isolate showed 99.8 % homology with the previously published sequences of UK (U39815.1) and Venezuela isolate (KU951901.1) and 97.0 % homology with the published sequences of Iraq isolate (LC328969.1). Phylogenetic tree revealed close relationship of TN isolate with Venezuela isolate, which had a common ancestor with the UK isolate and it is distantly related to Malaysia isolate of T. cati (KP71707).
Downloads
References
Badley, J.E., Grieve, R.B., Bowman, D.D., Glickman, L.T. and Rockey, J.H. (1987). Analysis of Toxocara canis larval excretory–secretory antigens: Physicochemical characterization and antibody recognition. Journal of Parasitology, 73: 593–600.
Chen, J., Liu, Q., Liu, G., Zheng, W.B., Hong, S.J., Sugiyama, H. and Zhu, X.Q. (2018). Toxocariasis: A silent threat with a progressive public health impact. Infectious Diseases of Poverty, 7: 59-71.
Despommier, D. (2003). Toxocariasis: Clinical aspects, epidemiology, medical ecology and molecular aspects. Clinical Microbiology Reviews, 16: 265–272.
Fong, M.Y., Lau, Y.L., Init, I., Jamaiah, I., Anuar, A.K. and Rahmah, N. (2003). Recombinant expression of Toxocara canis excretory-secretory antigen TES-120 in Escherichia coli. Southeast Asian Journal of Tropical Medicine and Public Health, 34(4): 723-726.
Gems, D. and Maizels, R.M. (1996). An abundantly expressed mucin- like protein from Toxocara canis infective larvae: The precursor of the larval surface coat glycoproteins. The Proceedings of the National Academy of Sciences, 93: 1665-1670.
Iddawela, R., Rajapakse, R., Perera, N. and Agatsuma, T. (2007). Characterization of Toxocara canis species specific excretory secretory antigen (TcES-57) and development of a double sandwich ELISA for diagnosis of visceral larva migrans. Korean Journal of Parasitology, 1:19–26.
Kavitha, K.T., Sreekumar, C., Latha, B.R., Mangala Gowri, A., Nagarajan, B. and Pazhanivel, N. (2019). Relationship between infective dose of larvae on pathology and antibody response in experimental toxocarosis in mice. Journal of Veterinary Parasitology, 33(2):13-23
Loukas, A., Doedens, A., Hintz, M. and Maizels, R.M. (2000). Identification of a new C-type lectin, TES-70, secreted by infective larvae of Toxocara canis, which binds to host ligands. Parasitology, 121: 545–54.
Magnaval, J.F., Glickman, L.T., Dorchies, P. and Morassin, B. (2001). Highlights of human toxocariasis. Korean Journal of Parasitology, 39: 1-11.
McGuinness, L.S. and Leder, K. (2014). Global Burden of Toxocariasis: A Common Neglected Infection of Poverty. Current Tropical Medicine Reports, 1: 52–61.
Mohamad, S., Azmi, N.C. and Noordin, R. (2009). Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120). Journal of Clinical Microbiology, 47(6): 1712-1717.
Sambrook, J. and Russell, D.W. (2001). Molecular cloning- A Laboratory Manual, 3rd Edition, (1-3). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA.
Smith, H., Holland, C., Taylor, M., Magnaval, J.F., Schantz, P. and Maizels, R. (2009). How common is human toxocariasis? Towards standardizing our knowledge. Trends in Parasitology, 25: 182–188.
Smith, H.V., Quinn, R., Kusel, J.R. and Girdwood, R.W.A. (1981). The effect of temperature and antimetabolites on antibody binding to the outer surface of second stage Toxocara canis larvae. Molecular and Biochemical Parasitology, 4:183–193.
Tetteh, K.K., Loukas, A. Tripp, C. and Maizels, R.M. (1999). Identification of abundantly expressed novel and conserved genes from the infective larval stage of Toxocara canis by an expressed sequence tag strategy. Infection and Immunity, 67: 4771-4779.
Watthanakulpanich, D., Smith, H.V., Hobb, G., Whalley, A.J. and Billington, D. (2008). Application of Toxocara canis excretory-secretory antigens and IgG subclass antibodies (IgG1- 4) in serodiagnostic assays of human toxocariasis. Acta Tropica, 106: 90–95.
Yamasaki, H., Araki, K., Lim, P.K.C., Zasmy, N., Mak, J.W., Radzan, T. and Aoki, T. (2000). Development of a highly specific recombinant Toxocara canis second stage larvae excretory-secretory antigen for immunodiagnosis of human toxocariasis. Journal of Clinical Microbiology, 38: 1409–1413.
Yamasaki, H., Razdan, T., Watanabe, Y., Mak, J.W., Ngah, Z., Lim, P.K.C., Kita, K. and Aoki, T. (1998). Molecular characterization of a cDNA encoding excretory secretory antigen from Toxocara canis second stage larvae and its application to the immunodiagnosis of human toxocariasis. Parasitology International, 47: 171-181.
Yunus, M.H., Siti, N.T.F., Izzati, Z.A.K. and Rahmah, N. (2018). A lateral flow rapid test for human toxocariasis developed using three Toxocara canis recombinant antigens. The American Journal of Tropical Medicine and Hygiene, 98(1): 32–38.
Downloads
Submitted
Published
Issue
Section
License
All the copy right belongs to the sponsoring Organization, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 51.